When I came across this recipe, I knew I had to give it a try...
Two new phase 3 studies published in The Lancet show that ultra long acting insulin, Degludec, an investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine.
The two studies included in total 1,635 participants and investigated insulin degludec compared to insulin...
Yesterday I went to the diabetes clinic for my tri-annual visit. I went there feeling guilty and ready to be scolded for my latest test results, especially…
I get feedback from people with type 1 diabetes who have had success implementing the Primal Blueprint, it can help manage the disease...
Yesterday I took part in a tweetchat with Dr. Richard Bessar of ABC News. Joining the chat were representatives from the Centers for Disease Control,…
I feel like a failure.
I got my latest blood test results yesterday and I was so disappointed with my hemoglobin A1C that I just can’t get over it.…
The College Diabetes Network's mission is to empower and improve the lives of students living with type 1 diabetes.
Hi all — Just a quick note to let you know that I’ll be participating in a tweet chat today, April 17th, at 1 pm on the Type 2 diabetes epidemic.…
Kamada, announced positive preliminary interim results from a Phase I/II clinical trial of D1-AAT, which includes the Alpha 1 protein, for the treatment of type 1 diabetes. D1-AAT may slow the progression of the type 1 diabetes, and may greatly reduce or eliminate, the need for insulin...
When Mike runs long distances, he knows to check his blood sugar frequently. He carries energy gels in his running pack and uses several of them in almost every long run. He's got the routine down to as close to perfect as you can get with diabetes. But what often takes him by surprise is the fact that many times even hours after a long run his blood sugar will continue to drop.